Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Robert A. Briddell"'
Autor:
Robert A. Briddell, Ian K. McNiece
Publikováno v:
Experimental Hematology. 29:3-11
Hematopoietic cells have the potential for providing benefit in a variety of clinical settings. These include cells for support of patients undergoing high-dose chemotherapy, as a target for replacement gene therapy, and as a source of cells for immu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75594b0f679115235508eaf5d03708a
https://doi.org/10.1016/s0301-472x(00)00610-x
https://doi.org/10.1016/s0301-472x(00)00610-x
Publikováno v:
Journal of Hematotherapy. 7:457-461
Ex vivo expansion of cord blood (CB) cells requires CD34+ cell selection before expansion to obtain optimal numbers of progenitor cells. As a preliminary step to preclinical development of CB expansion, we have evaluated two clinical scale selection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbf9bf19803cb381eb29a990fd90d5a
https://doi.org/10.1089/scd.1.1998.7.457
https://doi.org/10.1089/scd.1.1998.7.457
Autor:
Roy B. Jones, L. Chap, Ian McNiece, Elizabeth J. Shpall, William P. Sheridan, Michael Lill, C. F. LeMaistre, S. A. Turner, John A. Glaspy, M. D. Wiers, Dora Menchaca, Robert A. Briddell
Publikováno v:
Blood. 90:2939-2951
The safety and optimal dose and schedule of stem cell factor (SCF ) administered in combination with filgrastim for the mobilization of peripheral blood progenitor cells (PBPCs) was determined in 215 patients with high-risk breast cancer. Patients re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3f5b5fd048dd3354331556c8a81e88f
https://doi.org/10.1182/blood.v90.8.2939
https://doi.org/10.1182/blood.v90.8.2939
Autor:
Stefan Miltenyi, G Stoney, K. Zilm, Robert A. Briddell, Diether J. Recktenwald, Ian K. McNiece, Brent Kern
Publikováno v:
Journal of Hematotherapy. 6:5-11
The Amgen Cell Selection Device (ACSD) is a fully automated system based on the research scale magnetic-activated cell separation (MACS) system (Miltenyi Biotech GmbH, Bergisch Gladbach, Germany) for the selection of CD34+ cells. Leukapheresis produc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd3d69e91e8a1e1753ef0748e1ee30ec
https://doi.org/10.1089/scd.1.1997.6.5
https://doi.org/10.1089/scd.1.1997.6.5
Autor:
Frederick R. Appelbaum, Glenn H. Knitter, Ian McNiece, Robert G. Andrews, Scott D. Rowley, Robert A. Briddell
Publikováno v:
Blood. 85:15-20
We have previously shown that administration of low-dose recombinant human stem cell factor (rhSCF) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) to baboons mobilizes greater numbers of progenitor cells in the blood than does
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bec85354b869015e905fb6b5aa6071cc
https://doi.org/10.1182/blood.v85.1.15.bloodjournal85115
https://doi.org/10.1182/blood.v85.1.15.bloodjournal85115
Autor:
Melissa Bronsden, Frederick R. Appelbaum, David Myerson, Tim Opie, Glenn H. Knitter, Robert A. Briddell, Robert G. Andrews, Ian McNiece
Publikováno v:
Blood. 84:800-810
Recombinant human stem cell factor (rhSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) are synergistic in vitro in stimulating the proliferation of hematopoietic progenitor cells and their precursors. We examined the in vivo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41c98cd2708e9504bdf738ff6170dd9c
https://doi.org/10.1182/blood.v84.3.800.800
https://doi.org/10.1182/blood.v84.3.800.800
Publikováno v:
Blood. 84:795-799
In this study, we have compared the ability of recombinant human granulocyte colony-stimulating factor (rhG-CSF) alone and the combination of low doses of recombinant rat pegylated stem cell factor (rrSCF-PEG) plus rhG-CSF to mobilize peripheral bloo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b71a3320c4799f0254bbda32e6f1f5c
https://doi.org/10.1182/blood.v84.3.795.795
https://doi.org/10.1182/blood.v84.3.795.795
Publikováno v:
Stem Cells. 11:83-88
The use of cytokine mobilized peripheral blood progenitor cells (PBPC) in transplantation following chemotherapy has led to enhanced engraftment. Granulocyte-colony stimulating factor (G-CSF) has been shown in a number of clinical studies to be an ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3913ba9f78b18ae316f165fc0dc8c5b3
https://doi.org/10.1002/stem.5530110920
https://doi.org/10.1002/stem.5530110920
Publikováno v:
Blood. 82:1720-1723
Splenectomized mice treated for 7 days with pegylated recombinant rat stem cell factor (rrSCF-PEG) showed a dose-dependent increase in peripheral blood progenitor cells (PBPC) that have enhanced in vivo repopulating potential. A dose of rrSCF-PEG at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bc475be6da7d6463de52bd6c6f95a37
https://doi.org/10.1182/blood.v82.6.1720.1720
https://doi.org/10.1182/blood.v82.6.1720.1720
Autor:
Ronald Hoffman, Edward F. Srour, Tom Leemhuis, Robert A. Briddell, Susan Grigsby, John E. Brandt
Publikováno v:
Blood. 81:661-669
Although sustained production of committed human hematopoietic progenitor cells in long-term bone marrow cultures (LTBMC) is well documented, evidence for the generation and expansion of human primitive hematopoietic progenitor cells (PHPC) in such c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c0ac8364e738485ecf4d412c1879dff
https://doi.org/10.1182/blood.v81.3.661.661
https://doi.org/10.1182/blood.v81.3.661.661